One Stop Solution For In-Depth Market Research Reports

Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Japan Ophthalmic Devices Market

Japan Ophthalmic Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Product Code : MDHC00122447
Survey : Mordor Intelligence
Publish On : 12, August, 2022
Category : Healthcare and Pharmaceuticals
Study Area : North America (U.S. and Others), Europe (Germany, France, U.K. and Others), Asia-Pacific (Japan, China, India and Others), Rest of World (Brazil, Rest of Latin America, Middle East & Others)
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4950 / Question Form
5 User USD6750 / Question Form
Enterprise User USD9000 / Question Form
 - Alcon Inc.
- Bausch Health Companies Inc.
- Carl Zeiss Meditec AG
- Essilor International SA
- Johnson & Johnson
- Nidek Co. Ltd
- Topcon Corporation
- Ziemer Group AG

[Report Description]

The Japan Ophthalmic Devices & Drugs Market is expected to grow with a CAGR of 2% during the forecasted period. Certain factors that are driving the growth of the market include demographic shift, the impact of the prevalence of eye disease, technological advancements in the field of ophthalmology, and the rising geriatric population. The aging population is expected to burden all areas of healthcare, and ophthalmologists provide approximately 90% of their procedure-based services to seniors. As per the statistics published by the National Institute of Health 2020, in Japan, the leading cause of visual impairment is glaucoma, diabetic retinopathy, degenerative myopia, age-related macular degeneration, and cataract. In addition according to the Global Health Data Exchange, the prevalence of age-related macular degeneration is around 83,386 in 2018. The number is estimated to grow by 85,111 in 2019 Hence, the rising prevalence of eye disorders will lead to the growing demand for drugs and devices for diagnosis and treatment.

Key Market Trends

Cataract Segment is Expected to Show Better Growth in the Forecast Years

Based on disease, the market is segmented into glaucoma, cataract, age-related macular degeneration, inflammatory diseases, refractive disorders and other diseases. As per the Global Health Data Exchange, it is estimated that the prevalence of cataract in Japan is 1,231,522 in 2018. It is further increased by 1,266,085 in 2019. Cataract surgery remains the most effective way to help restore vision for people with cataracts. In addition, the prevalence of Glaucoma diseases is also rising in Japan. For instance according to the Global Health Data Exchange there are around 238,019 new cases of glaucoma reported in the year 2019. Hence, with the rising burden of eye disease in Japan, the market is expected to grow in the forecast period.

Competitive Landscape

The Japan Ophthalmic Devices & Drugs Market is fragmented competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Alcon Inc., Bausch Health Companies Inc., Carl Zeiss Meditec AG, Essilor International SA, Johnson & Johnson, Nidek Co. Ltd, Topcon Corporation, Ziemer Group AG

Additional Benefits:

  • The market estimate (ME) sheet in Excel format

  • 3 months of analyst support

1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Demographic Shift and Impact of Prevalence of Eye Disease
4.2.2 Technological Advancements in the Field of Ophthalmology
4.3 Market Restraints
4.3.1 Higher Cost of the Ophthalmic Devices and Treatment
4.4 Porter s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Product
5.1.1 Devices Surgical Devices Intraocular Lenses Ophthalmic Lasers Other Surgical Devices Diagnostic Devices
5.1.2 Drugs Glaucoma Drugs Retinal Disorder Drugs Dry Eye Drugs Allergic Conjunctivitis and Inflammation Drugs Other Drugs
5.2 By Disease
5.2.1 Glaucoma
5.2.2 Cataract
5.2.3 Age-Related Macular Degeneration
5.2.4 Inflammatory Diseases
5.2.5 Refractive Disorders
5.2.6 Other Diseases

6.1 Company Profiles
6.1.1 Alcon Inc.
6.1.2 Bausch Health Companies Inc.
6.1.3 Carl Zeiss Meditec AG
6.1.4 Essilor International SA
6.1.5 Johnson & Johnson
6.1.6 Nidek Co. Ltd
6.1.7 Topcon Corporation
6.1.8 Ziemer Group AG


Shibuya data count

Shibuya Data Count is a reseller offering a variety of market research reports from different industries, provided by a global team of experienced research professionals who ensure the most reliable and up-to-date research analysis reports.

Recommended reports